![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Addex Therapeutics Ltd | LSE:0QNV | London | Ordinary Share | CH0029850754 | ADDEX THERAPEUTICS ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 3.02 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.61M | -10.56M | -0.0573 | -52.71 | 556.75M |
Date | Time | Source | Headline |
---|---|---|---|
08/1/2025 | 06:00 | UKREG | Addex to Present at the 2025 Swiss Equities Baader Conference |
22/11/2024 | 06:00 | UKREG | Addex Reports Third Quarter 2024 Financial Results and Provides Corporate.. |
11/11/2024 | 06:00 | UKREG | Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to.. |
30/9/2024 | 05:00 | UKREG | Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial.. |
19/9/2024 | 05:00 | UKREG | Addex Provisional 2024 Half-Year and Second Quarter Result increased from a.. |
04/9/2024 | 05:00 | UKREG | Addex to Participate in the H.C. Wainwright 26th Annual Global Investment.. |
27/8/2024 | 05:00 | UKREG | Addex and Indivior Select Clinical Candidates from GABAB Positive.. |
22/7/2024 | 05:00 | UKREG | Addex’s Partner Discontinues ADX71149 development in Epilepsy |
15/7/2024 | 05:00 | UKREG | Addex Presents Positive Results from GABAB PAM Cough Program at the.. |
12/7/2024 | 05:00 | UKREG | Addex To Present at the Thirteenth London International Cough Symposium.. |
1 Year Addex Therapeutics Chart |
Intraday Addex Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions